These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1582018)
41. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle. Lehtiö H; Mäenpää PH Clin Chim Acta; 1977 Oct; 80(1):181-5. PubMed ID: 908140 [TBL] [Abstract][Full Text] [Related]
42. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453 [TBL] [Abstract][Full Text] [Related]
43. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Xu G; Schmid HR; Lu X; Liebich HM; Lu P Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924 [TBL] [Abstract][Full Text] [Related]
44. [Determination of pseudouridine in serum by high performance liquid chromatography]. Hu Y; Tang Q; Liu B Se Pu; 1997 Jul; 15(4):349-51. PubMed ID: 15739475 [TBL] [Abstract][Full Text] [Related]
45. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters. Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786 [TBL] [Abstract][Full Text] [Related]
46. Urinary nucleosides as biological markers for patients with colorectal cancer. Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285 [TBL] [Abstract][Full Text] [Related]
47. Reference values for nucleosides and nucleobases in cerebrospinal fluid of children. Gerrits GP; Haagen AA; De Abreu RA; Monnens LA; Gabreëls FJ; Trijbels FJ; Theeuwes AL; van Baal JM Clin Chem; 1988 Jul; 34(7):1439-42. PubMed ID: 3390913 [TBL] [Abstract][Full Text] [Related]
48. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides. Masuda M; Nishihira T; Itoh K; Mizugaki M; Ishida N; Mori S Cancer; 1993 Dec; 72(12):3571-8. PubMed ID: 8252470 [TBL] [Abstract][Full Text] [Related]
49. Breast cancer prognostic significance of some modified urinary nucleosides. Sasco AJ; Rey F; Reynaud C; Bobin JY; Clavel M; Niveleau A Cancer Lett; 1996 Nov; 108(2):157-62. PubMed ID: 8973589 [TBL] [Abstract][Full Text] [Related]
50. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897 [TBL] [Abstract][Full Text] [Related]
51. Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer. Daghir-Wojtkowiak E; Struck-Lewicka W; Waszczuk-Jankowska M; Markuszewski M; Kaliszan R; Markuszewski MJ Biomark Med; 2015; 9(6):577-95. PubMed ID: 26079962 [TBL] [Abstract][Full Text] [Related]
52. A fast capillary electrophoresis method for separation and quantification of modified nucleosides in urinary samples. Jiang Y; Ma Y Anal Chem; 2009 Aug; 81(15):6474-80. PubMed ID: 19552424 [TBL] [Abstract][Full Text] [Related]
53. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE. Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143 [TBL] [Abstract][Full Text] [Related]
54. Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. II. Evaluation of human sera. Hartwick RA; Krstulovic AM; Brown PR J Chromatogr; 1979 Dec; 186():659-76. PubMed ID: 546939 [TBL] [Abstract][Full Text] [Related]
55. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine. Nakano K; Yasaka T; Schram KH; Reimer ML; McClure TD; Nakao T; Yamamoto H J Chromatogr; 1990 Aug; 515():537-46. PubMed ID: 2283377 [TBL] [Abstract][Full Text] [Related]
57. Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer. Zhang YR; Shi L; Wu H; Tang DD; Wang SM; Liu HM; Zhang LR; Song DK Tumori; 2014; 100(6):660-6. PubMed ID: 25688500 [TBL] [Abstract][Full Text] [Related]
58. Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. I. Chromatographic methodology. Hartwick RA; Assenza SP; Brown PR J Chromatogr; 1979 Dec; 186():647-58. PubMed ID: 546938 [TBL] [Abstract][Full Text] [Related]
59. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer. Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242 [TBL] [Abstract][Full Text] [Related]
60. Quantitative high-performance liquid chromatography of nucleosides and bases in human plasma. Taylor GA; Dady PJ; Harrap KR J Chromatogr; 1980 Oct; 183(4):421-31. PubMed ID: 7430295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]